To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications “off-label” against SARS-CoV-2. Fluoxetine inhibited SARS-CoV-2 at a concentration of 0.8 µg/ml significantly in these screenings, and the EC50 was determined with 387 ng/ml. Furthermore, Fluoxetine reduced viral infectivity in precision-cut human lung slices showing its activity in relevant human tissue targeted in severe infections. Fluoxetine treatment resulted in a decrease in viral protein expression. Fluoxetine is a racemate consisting of both stereoisomers, while the S-form is the dominant serotonin reuptake inhibitor. We found that both isomers show similar activity on the virus, indicating that the R-form might specifically be used for SARS-CoV-2 treatment. Fluoxetine inhibited neither Rabies virus, human respiratory syncytial virus replication nor the Human Herpesvirus 8 or Herpes simplex virus type 1 gene expression, indicating that it acts virus-specific. Moreover, since it is known that Fluoxetine inhibits cytokine release, we see the role of Fluoxetine in the treatment of SARS-CoV-2 infected patients of risk groups.
【저자키워드】 SARS-CoV-2, viral infection, viral epidemiology, 【초록키워드】 Treatment, Gene Expression, Human, Remdesivir, clinical trials, risk, cytokine, drug, medications, virus, Replication, Viral, viral infectivity, respiratory syncytial virus, human lung, herpesvirus, medication, inhibitor, Rabies virus, Concentration, Fluoxetine, herpes simplex virus, Serotonin, tissue, SARS-CoV-2 infected patients, severe infections, protein expression, cytokine release, effective inhibitor, off-label, herpes simplex, SARS-CoV-2 treatment, EC50, racemate, dominant, decrease, screenings, significantly, inhibit, inhibited, approved, reduced, screened, was determined, in viral, groups, circumvent, time-consuming, isomer, Raby, SARS-CoV-2 infected patient, 【제목키워드】 inhibitor, human lung tissue, inhibit,